We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Serenity prayer time
Some managers say bond prices have fallen too far relative to the risk of default
Carolyn Everson co-founded Pets.com and helped build Facebook’s advertising business
Activist investor backs away from demand to ditch sports network after chief executive’s remarks
The FT’s award-winning markets blog offers advice to personal savers
Shares rise as Daniel Loeb takes ‘significant’ new stake in entertainment group
Market regime change is here. It won’t be pretty
Prominent veterans of Wall St proxy battles are taking a more low-key approach
Campaign ends as Dan Loeb’s London unit appoints investor-backed independent director
Dan Loeb says ‘juvenile antics’ by rebel shareholders ‘smack of desperation and inexperience’
Insurgents led by AVI complained about valuation gap between main and feeder funds
Hedge fund among several to score large gains on electric vehicle start-up
Plus, royalties are music to private equity’s ears and the family with a Wall Street legacy
Group led by Daniel Loeb accuses oil supermajor of ‘incoherent’ strategies
Shareholders frustrated over discount between share price and value of underlying assets
Buying into private companies seen as way to bypass overcrowded IPOs
UK investment trust denies shareholders a vote on how to address share price discount
Activist investors must keep their nerve to influence the party
Plus, an unexpected casualty from the fall of Archegos, and a decades-old billionaires’ rivalry comes full circle
Asset Value Investors complains about performance of well-known activist’s fund
Activist hedge fund steps up focus on private markets as it urges Intel to rethink manufacturing
Activist hedge fund led by Daniel Loeb demands strategy shake-up
Diverging expectations offer opportunities for the likes of Dan Loeb and Bill Ackman
Billionaire Jeffrey Talpins also positioned himself for market rotation with bet on Pfizer findings
Activist investor calls for radical shift of focus from box office to Disney+ arm
International Edition
